Sunshine Insurance Group Company Limited (6963.HK)
Shenzhen, CN
Sunshine Insurance Group Company Limited operates within China, providing a diverse range of insurance policies. Its offerings encompass life insurance products, as well as a comprehensive suite of property and casualty coverage, including vehicle, accidental injury, temporary health, surety, indemnity, agricultural, and commercial real estate insurance. Established in Shenzhen, China, in 2004, the company was initially known as Sunshine Insurance Holdings Co., Ltd. until its rebranding to Sunshine Insurance Group Company Limited in 2007.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.91% | +2.31% | -1.67% | -9.69% | -2.21% | -8.76% | +7.60% | -18.24% | -39.28% | -39.28% | -39.28% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Insurance - Diversified: +15.2%+17.4% ★ Q4'25: +45.5% (vs Q4'23)
-
EPS growth Insurance - Diversified: +25.3%+12.8% Q4'25: +241.5% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Diversified: +30.2%+7.3% Q4'25: +94.2% (vs Q4'23)
-
EBIT margin Insurance - Diversified: +13.5%+9.0% Q4'25: +5.3% (vs Q4'23)
-
ROIC Insurance - Diversified: +4.2%+8.1% ★ Q4'25: +11.0% (vs Q4'23)
-
Share dilution Insurance - Diversified: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Diversified: -0.05×5.99× Q4'25: 4.80× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 7 EPS Ana. |
Dec 2027 4 Rev. Ana. 7 EPS Ana. |
Dec 2028 2 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
66.60B
est: 121.37B (-45.1%)
|
72.05B
est: 115.64B (-37.7%)
|
75.22B
est: 90.64B (-17.0%)
|
88.28B
est: 68.44B (+29.0%)
|
89.10B
68.29B – 101.29B
+30.2% YoY
|
93.57B
72.30B – 106.71B
+5.0% YoY
|
103.71B
79.82B – 118.10B
+10.8% YoY
|
| EBITDA |
7.47B
est: 13.16B (-43.2%)
|
8.59B
est: 12.54B (-31.5%)
|
11.06B
est: 9.83B (+12.5%)
|
7.97B
est: 7.42B (+7.4%)
|
9.66B
7.41B – 10.98B
+30.2% YoY
|
10.15B
7.84B – 11.57B
+5.0% YoY
|
11.25B
8.66B – 12.81B
+10.8% YoY
|
| EBIT |
5.80B
est: 11.10B (-47.7%)
|
6.89B
est: 10.57B (-34.9%)
|
9.41B
est: 8.29B (+13.6%)
|
7.97B
est: 6.26B (+27.4%)
|
8.15B
6.24B – 9.26B
+30.2% YoY
|
8.56B
6.61B – 9.76B
+5.0% YoY
|
9.48B
7.30B – 10.80B
+10.8% YoY
|
| Net Income |
4.49B
est: 5.86B (-23.3%)
|
3.74B
est: 4.48B (-16.6%)
|
5.45B
est: 4.94B (+10.2%)
|
6.14B
est: 6.44B (-4.6%)
|
6.81B
5.63B – 7.30B
+5.7% YoY
|
7.60B
6.14B – 8.55B
+11.6% YoY
|
8.50B
5.96B – 10.04B
+11.9% YoY
|
| SGA |
2.91B
est: 6.77B (-57.0%)
|
3.48B
est: 6.45B (-46.1%)
|
2.84B
est: 5.06B (-43.9%)
|
—
est: 3.82B (-100.0%)
|
4.97B
3.81B – 5.65B
+30.2% YoY
|
5.22B
4.03B – 5.95B
+5.0% YoY
|
5.79B
4.45B – 6.59B
+10.8% YoY
|
| EPS |
0.47
est: 0.51 (-7.7%)
|
0.32
est: 0.39 (-17.8%)
|
0.47
est: 0.43 (+9.3%)
|
0.53
est: 0.56 (-5.3%)
|
0.59
0.49 – 0.63
+5.7% YoY
|
0.66
0.53 – 0.74
+11.6% YoY
|
0.74
0.52 – 0.87
+11.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | JPMorgan International Value ETF JIVE | 0.14% | 4.68M | 0.55% |
| 2 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.09% | 310.3K | 0.58% |
| 3 | Franklin FTSE China UCITS ETF FLXC.L | 0.04% | 626.2K | 0.19% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 46.0K | 0.42% |
| 5 | Franklin FTSE China ETF FLCH | 0.04% | 103.8K | 0.19% |
| 6 | Avantis Emerging Markets Value ETF AVES | 0.02% | 310.2K | 0.36% |
| 7 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 34.2K | 0.35% |
| 8 | Goldman Sachs MarketBeta Emerging Markets Equity ETF GSEE | 0.01% | 17.1K | 0.45% |
| 9 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 604.4K | 0.17% |
| 10 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.01% | 604.4K | 0.17% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jihai Peng | Co-CEO, CFO, Chief Investment Officer, Head of Investment, Deputy GM & Executive Director | 6M | male |
| Ke Li | Co-CEO, GM & Executive Director | 5M | male |
| Weigong Zhang | Founder, Executive Chairman & Chief Executive Officer | 5M | male |
| Xiaopeng Wang | Executive Director | — | male |
| Kwok Yin Lau | Joint Company Secretary | — | male |
| Gaoyong Shu | Head of Securities Affairs & Joint Company Secretary | — | male |
| Rui Nie | Chief Compliance Officer & Chief Risk Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6963.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
